JP2019529482A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019529482A5 JP2019529482A5 JP2019516976A JP2019516976A JP2019529482A5 JP 2019529482 A5 JP2019529482 A5 JP 2019529482A5 JP 2019516976 A JP2019516976 A JP 2019516976A JP 2019516976 A JP2019516976 A JP 2019516976A JP 2019529482 A5 JP2019529482 A5 JP 2019529482A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- keto
- hydroxytyrosol
- acetyl
- boswellic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- JUUBCHWRXWPFFH-UHFFFAOYSA-N Hydroxytyrosol Chemical compound OCCC1=CC=C(O)C(O)=C1 JUUBCHWRXWPFFH-UHFFFAOYSA-N 0.000 claims 18
- 239000000203 mixture Substances 0.000 claims 17
- HMMGKOVEOFBCAU-BCDBGHSCSA-N 3-Acetyl-11-keto-beta-boswellic acid Chemical compound C1C[C@@H](OC(C)=O)[C@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C)[C@H](C)[C@H]5C4=CC(=O)[C@@H]3[C@]21C HMMGKOVEOFBCAU-BCDBGHSCSA-N 0.000 claims 9
- HMMGKOVEOFBCAU-UHFFFAOYSA-N AKBA Natural products C1CC(OC(C)=O)C(C)(C(O)=O)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CC(=O)C3C21C HMMGKOVEOFBCAU-UHFFFAOYSA-N 0.000 claims 9
- 229940095066 hydroxytyrosol Drugs 0.000 claims 9
- 235000003248 hydroxytyrosol Nutrition 0.000 claims 9
- 241001465754 Metazoa Species 0.000 claims 4
- 230000037396 body weight Effects 0.000 claims 4
- 241000282472 Canis lupus familiaris Species 0.000 claims 3
- 240000007817 Olea europaea Species 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 2
- 235000002725 Olea europaea Nutrition 0.000 claims 2
- 210000002808 connective tissue Anatomy 0.000 claims 2
- 241000283690 Bos taurus Species 0.000 claims 1
- 240000007551 Boswellia serrata Species 0.000 claims 1
- 235000012035 Boswellia serrata Nutrition 0.000 claims 1
- 241000282832 Camelidae Species 0.000 claims 1
- 241000283086 Equidae Species 0.000 claims 1
- 241000282326 Felis catus Species 0.000 claims 1
- 241000282412 Homo Species 0.000 claims 1
- 239000006227 byproduct Substances 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 230000028709 inflammatory response Effects 0.000 claims 1
- 239000000047 product Substances 0.000 claims 1
- 230000000451 tissue damage Effects 0.000 claims 1
- 231100000827 tissue damage Toxicity 0.000 claims 1
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022082301A JP7341596B2 (ja) | 2016-10-04 | 2022-05-19 | 炎症メディエーターのレベルを低減するための組成物及び方法 |
| JP2023137408A JP7562225B2 (ja) | 2016-10-04 | 2023-08-25 | 炎症メディエーターのレベルを低減するための組成物及び方法 |
| JP2024163552A JP2024166415A (ja) | 2016-10-04 | 2024-09-20 | 炎症メディエーターのレベルを低減するための組成物及び方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662403807P | 2016-10-04 | 2016-10-04 | |
| US62/403,807 | 2016-10-04 | ||
| PCT/US2017/028857 WO2018067200A1 (en) | 2016-10-04 | 2017-04-21 | Compositions comprising hydroxytyrosol and boswellic acid |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022082301A Division JP7341596B2 (ja) | 2016-10-04 | 2022-05-19 | 炎症メディエーターのレベルを低減するための組成物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019529482A JP2019529482A (ja) | 2019-10-17 |
| JP2019529482A5 true JP2019529482A5 (cg-RX-API-DMAC7.html) | 2020-05-28 |
| JP7079551B2 JP7079551B2 (ja) | 2022-06-02 |
Family
ID=58664857
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019516976A Active JP7079551B2 (ja) | 2016-10-04 | 2017-04-21 | ヒドロキシチロソールおよびボスウェリン酸を有する組成物 |
| JP2022082301A Active JP7341596B2 (ja) | 2016-10-04 | 2022-05-19 | 炎症メディエーターのレベルを低減するための組成物及び方法 |
| JP2023137408A Active JP7562225B2 (ja) | 2016-10-04 | 2023-08-25 | 炎症メディエーターのレベルを低減するための組成物及び方法 |
| JP2024163552A Pending JP2024166415A (ja) | 2016-10-04 | 2024-09-20 | 炎症メディエーターのレベルを低減するための組成物及び方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022082301A Active JP7341596B2 (ja) | 2016-10-04 | 2022-05-19 | 炎症メディエーターのレベルを低減するための組成物及び方法 |
| JP2023137408A Active JP7562225B2 (ja) | 2016-10-04 | 2023-08-25 | 炎症メディエーターのレベルを低減するための組成物及び方法 |
| JP2024163552A Pending JP2024166415A (ja) | 2016-10-04 | 2024-09-20 | 炎症メディエーターのレベルを低減するための組成物及び方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US11241444B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3522874B1 (cg-RX-API-DMAC7.html) |
| JP (4) | JP7079551B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN109789110A (cg-RX-API-DMAC7.html) |
| AU (3) | AU2017340126B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3039233A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3040765T3 (cg-RX-API-DMAC7.html) |
| PL (1) | PL3522874T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018067200A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109789110A (zh) | 2016-10-04 | 2019-05-21 | 纽崔玛氏科技有限责任公司 | 包含羟基酪醇和乳香酸的组合物 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6358542B2 (en) | 1999-12-20 | 2002-03-19 | Usana, Inc. | Antioxidant compositions extracted from olives and olive by-products |
| WO2002018310A1 (en) | 2000-09-01 | 2002-03-07 | Creagri, Inc. | Method of obtaining a hydroxytyrosol-rich composition from vegetation water |
| US7713569B2 (en) | 2000-09-01 | 2010-05-11 | Creagri, Inc. | Hydroxytyrosol-rich composition from olive vegetation water and method of use thereof |
| WO2003068171A2 (en) | 2002-02-13 | 2003-08-21 | Creagri, Inc. | Method and composition for treatment of inflammation and aids-associated neurological disorders |
| WO2003077860A2 (en) | 2002-03-13 | 2003-09-25 | Biophysica, Inc. | BOSWELLIN COMPOSITIONS ENHANCED WITH 3-β-ACETYL-11-KETO-β-BOSWELLIC ACID (“AKBA”), INDUSTRIAL MANUFACTURE AND THEIR USES |
| EP1582512A1 (en) | 2004-03-31 | 2005-10-05 | Cognis IP Management GmbH | Process for obtaining hydroxytyrosol from olive leaves extracts |
| WO2005123649A1 (en) | 2004-06-18 | 2005-12-29 | Ganga Raju Gokaraju | NOVEL ANALOGS OF 3-O-ACETYL-11-KETO-β-BOSWELLIC ACID |
| US20080300198A1 (en) * | 2004-08-09 | 2008-12-04 | Kathleen Matt | Olive Compositions and Methods for Treating Inflammatory Conditions |
| WO2008006582A1 (en) | 2006-07-14 | 2008-01-17 | Dsm Ip Assets B.V. | Compositions comprising magnolol or honokiol and other active agents for the treatment of inflammatory diseases |
| JP5339373B2 (ja) | 2006-07-14 | 2013-11-13 | ディーエスエム アイピー アセッツ ビー．ブイ． | 組成物および炎症障害の治療、共治療または予防のためのその使用 |
| JP2008120716A (ja) | 2006-11-10 | 2008-05-29 | Eisai Food Chemical Kk | 抗炎症剤 |
| KR101682512B1 (ko) | 2008-09-15 | 2016-12-05 | 라일라 뉴트라슈티칼스 | 보스웰리아 세라타 추출물을 포함하는 상승적인 항-염증 조성물 |
| CN102451428A (zh) * | 2010-10-14 | 2012-05-16 | 中国中医科学院广安门医院 | 可用于治疗类风湿关节炎的中药组合物 |
| EP2925307B1 (en) * | 2012-11-30 | 2020-10-28 | McCord, Darlene E. | Hydroxytyrosol and oleuropein compositions for induction of dna damage, cell death and lsd1 inhibition |
| CN109789110A (zh) | 2016-10-04 | 2019-05-21 | 纽崔玛氏科技有限责任公司 | 包含羟基酪醇和乳香酸的组合物 |
| US10342802B2 (en) | 2016-10-04 | 2019-07-09 | Nutramax Laboratories, Inc. | Compositions comprising hydroxytyrosol and boswellic acid |
-
2017
- 2017-04-21 CN CN201780061735.7A patent/CN109789110A/zh active Pending
- 2017-04-21 CN CN202510507272.9A patent/CN120241745A/zh active Pending
- 2017-04-21 EP EP17720995.4A patent/EP3522874B1/en active Active
- 2017-04-21 JP JP2019516976A patent/JP7079551B2/ja active Active
- 2017-04-21 PL PL17720995.4T patent/PL3522874T3/pl unknown
- 2017-04-21 CA CA3039233A patent/CA3039233A1/en active Pending
- 2017-04-21 WO PCT/US2017/028857 patent/WO2018067200A1/en not_active Ceased
- 2017-04-21 ES ES17720995T patent/ES3040765T3/es active Active
- 2017-04-21 AU AU2017340126A patent/AU2017340126B2/en active Active
- 2017-04-21 EP EP25185237.2A patent/EP4623994A3/en active Pending
-
2020
- 2020-03-26 US US16/830,454 patent/US11241444B2/en active Active
-
2021
- 2021-12-22 US US17/559,571 patent/US11980624B2/en active Active
-
2022
- 2022-05-19 JP JP2022082301A patent/JP7341596B2/ja active Active
-
2023
- 2023-05-31 AU AU2023203427A patent/AU2023203427B2/en active Active
- 2023-08-25 JP JP2023137408A patent/JP7562225B2/ja active Active
-
2024
- 2024-04-24 US US18/644,758 patent/US20240285648A1/en active Pending
- 2024-09-20 JP JP2024163552A patent/JP2024166415A/ja active Pending
-
2025
- 2025-04-23 AU AU2025202875A patent/AU2025202875A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2018000262A (es) | Uso de indazoles sustituidos para el tratamiento y la prevención de enfermedades en animales | |
| EP3207931A3 (en) | Protective effect of dmpc, dmpg, dmpc/dmpg, egpg, lysopg and lysopc against drugs that cause channelopathies | |
| PH12019502241A1 (en) | Berberine alkaloids in the prevention and/or treatments of intestinal disease | |
| BR112012010689B8 (pt) | mistura antifúngica com organismo fúngico | |
| CY1122335T1 (el) | Μουσκαρινικοι ανταγωνιστες και συνδυασμοι τους για τη θεραπευτικη αντιμετωπιση της νοσου των αναπνευστικων οδων στα αλογα | |
| CL2014003119A1 (es) | Método de tratamiento no terapéutico de aves de corral, cerdos o peces para reducir la relación de conversión de alimento o incrementar su ganancia de peso corporal, que comprende la adminsitración oral de beta-alanina; y alimento para aves, cerdos o peces, que comprende beta-alanina como aditivo. | |
| Biesdorf et al. | Dopamine in the nucleus accumbens core, but not shell, increases during signaled food reward and decreases during delayed extinction | |
| NZ706573A (en) | Ciclesonide for the treatment of airway disease in horses | |
| JP2019529482A5 (cg-RX-API-DMAC7.html) | ||
| BR112019003890A2 (pt) | uso de oligossacarídeos de leite humano em engordamento de bezerros | |
| JP2023085448A (ja) | 乳酸菌により非ヒト動物の異常な感情又は行動を予防又は治療する方法 | |
| MX2020010243A (es) | Composiciones bucales y metodos para animales. | |
| MX2018010495A (es) | Nuevos productos inmunobiologicos. | |
| JP2016513738A5 (cg-RX-API-DMAC7.html) | ||
| JP2003012555A (ja) | 動伴侶動物における問題行動を防止するための医薬組成物および方法 | |
| GB2522271A (en) | Herbal composition and its use for modifying animal behavior | |
| JP6227594B2 (ja) | 動物の発毛促進用組成物及びその配合物 | |
| JP2018043942A5 (cg-RX-API-DMAC7.html) | ||
| Hisham et al. | Physical and performance characteristics of Rajapalayam dogs of Tamil Nadu | |
| Giri et al. | Diagnosis and therapeutic management of oestrosis in small ruminants | |
| Andrea | Acupuncture treatment of pseudo-pregnancy in a female dog: a case report | |
| Du Pisanie | Scabby mouth: dangerous for man and animal | |
| Pati et al. | Therapeutic management of puppy pyoderma | |
| Scott | House dust mites trigger asthma attacks through trickery | |
| Ghulam Jilany et al. | Ciprofloxacin; the frequent use in poultry and its consequences on human health |